Delaying surgery does not appear to harm men on active surveillance (AS) for prostate cancer (PCa), a new study finds. Over 3 years after radical surgery, men who delayed surgery and those who had immediate surgery had similar rates of biochemical recurrence. Read the article.
Delaying RP with Active Surveillance Carries No Greater Risks Read More »
PSA production may be lower in African-American than Caucasian men with low-risk prostate cancer (PCa), a new study suggests. If confirmed, the finding could impact active surveillance criteria for black patients. Read the article.
Black Men with Low-Risk Prostate Cancer Produce Less PSA Read More »
High-intensity focused ultrasound (HIFU) is a treatment option for low- and intermediate-risk prostate cancer and more recently has been used as salvage therapy after failed radiation therapy. The article presents a case of local recurrence with biochemical failure after radical prostatectomy and salvage external beam radiation therapy with salvage HIFU without biochemical recurrence at 20 months. Read the article.
Doctors at Toronto’s Sunnybrook Hospital are exploring a new, more precise way of administering radiation therapy to patients with prostate cancer. Stereotactic ablative body radiotherapy, or SABR, allows doctors to give patients a high dose of radiation in a short period of time, replacing the long hours of treatment commonly associated with radiation therapy. “What’s really revolutionary about this is that patients used to have to come for up to eight weeks of radiotherapy — one treatment per day, five days a week,” said Sunnybrook oncologist Andrew Loblaw. “Now with this new trial, we’ve been able to show that you
Toronto hospital tests new, high-precision method of prostate cancer treatment Read More »
A new study showed a “significant decrease” in the erectile function score of most men after biopsy, and the drop was independent of age, cancer diagnosis, and previous biopsy status, report the study authors. Read the article.
ED Induced by Prostate Biopsy Likely ‘Underestimated’ Read More »
Hamilton researchers are attempting to create a prostate cancer vaccine that would use viruses to destroy cancer cells and trigger an immune response. Funded primarily by a $5-million grant from popular fundraiser Movember and Prostate Cancer Canada, the vaccine will be manufactured in Hamilton and Ottawa and tested on patients who currently have no other course of treatment. Read the article.
McMaster gets $5M to test prostate cancer vaccine Read More »
The US Food and Drug Administration has approved SonaCare Medical’s Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined prostate disease while preserving surrounding healthy tissue, without radiation or surgery. Read the article.
FDA Approves First Focused Ultrasound System for Treating the Prostate Read More »
Antioxidants are supposed to keep your cells healthy. That is why millions of people gobble supplements like vitamin E and beta-carotene each year. Today, however, a new study adds to a growing body of research suggesting these supplements actually have a harmful effect in one serious disease: cancer. Read the article.
Antioxidants May Make Cancer Worse Read More »
Antioxidants — which include vitamins C and E and beta-carotene, and are contained in thousands of foods — are thought to protect cells from damage by acting as defenders against something called “free radicals” which the body produces as a part of metabolism or that can enter through the environment. That’s all great for normal cells. But what researchers at the University of Texas Southwestern Medical Center found is that antioxidants can work their magic on cancerous cells, too — turbo-charging the process by which they grow and spread. Read the article.
The latest study about antioxidants is terrifying. Read More »
Although popular, such supplements do not appear to lower the risk for experiencing radiation treatment side effects; the risk that localized cancer will spread; or the risk that prostate cancer patients will die from their disease, researchers found. “We suspected that these pills were junk. Our study confirmed our suspicion,” said study lead author Dr. Nicholas Zaorsky, resident physician in radiation oncology at the Fox Chase Cancer Center in Philadelphia. Read the article.
Do men’s health supplements help prostate cancer patients? Read More »